ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,040, issued on May 12, was assigned to KSQ Therapeutics Inc. (Cambridge, Mass.).
"Compositions of substituted pyrazolopyrimidines and uses thereof" was invented by Hanlan Liu (Lexington, Mass.) and Robert M. Wenslow Jr. (Cream Ridge, N.J.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Pharmaceutical formulations comprising substituted pyrazolopyrimidines are disclosed herein. Also disclosed are amorphous solid dispersions comprising substituted pyrazolopyrimidines, processes for preparing these amorphous solid dispersions, pharmaceutical compositions comprising such dispersions, and methods of use thereof."
The patent was filed on Jan. 14, 2021, und...